Michelle Nguyen-McCarty

485 citations
8 papers · 398 indexed · h-index 7

Michelle Nguyen-McCarty

8 papers receiving 392 citations

Peers

Michelle Nguyen-McCarty
Comparison fields: 5 of 65
  • Hematology 87
  • Genetics 59
  • Cancer Research 67
  • Molecular Biology 283
  • Aging 6
Replace Priti Anand with:
Priti Anand United States
Amy Andreucci United States
Bishwa Ghimire Finland
Raziel Lurie Israel
Sarah Schouteden Belgium
Rosalind C. Williamson United Kingdom
Sara Rohrabaugh United States
Charlotta Böiers Sweden
Alessandra Perfetti Italy
Suna Önengüt United States
Michelle Nguyen-McCarty relative to Priti Anand United States Priti Anand's profile →
Citations per field
00.5×3.1×
Priti Anand · 1×
Citations per year

Countries citing papers authored by Michelle Nguyen-McCarty

Since Specialization
Citations

This map shows the geographic impact of Michelle Nguyen-McCarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Nguyen-McCarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Nguyen-McCarty more than expected).

Fields of papers citing papers by Michelle Nguyen-McCarty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Nguyen-McCarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Nguyen-McCarty. The network helps show where Michelle Nguyen-McCarty may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michelle Nguyen-McCarty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michelle Nguyen-McCarty Line = papers co-authored together Michelle Nguyen-McCarty links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 20197
2 201721
3 20151
4 201558
5 201350
6 2012179
7 201159
8 201023

About Michelle Nguyen-McCarty

Michelle Nguyen-McCarty is a scholar working on Complementary and alternative medicine, Molecular Biology and Orthopedics and Sports Medicine, having authored 8 papers that have together received 398 indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (5 papers), Epigenetics and DNA Methylation (2 papers), Cardiovascular and exercise physiology (2 papers), Autophagy in Disease and Therapy (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Computational Drug Discovery Methods (1 paper) and Growth Hormone and Insulin-like Growth Factors (1 paper). The work is most often cited by research in Hematology (87 citations), Genetics (59 citations) and Cancer Research (67 citations). Michelle Nguyen-McCarty has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Peter S. Klein, Elizabeth O. Hexner, Jian Huang, Gwenn Danet-Desnoyers, M. Celeste Simon, Amar J. Majmundar, Rickson C. Mesquita, Arjun G. Yodh, Nicolas Skuli and Meeri N. Kim. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026